Analysis Writedowns and growing pains ahead for Tilray 2.0, analyst says But Chris Damas of the BCMI Cannabis Report notes the Aphria-merged firm will command a strong presence in Europe's medical cannabis market Jared GnamMay 3, 2021
Industry update Valens enters US CBD market with purchase of Florida firm The Canadian pot product company says its Green Roads deal represents only the first step in its US expansion strategy Jared GnamApril 27, 2021
Industry update Tilray reduces required shareholder vote count to 1/3 for Aphria merger The Canadian weed firm urges all shareholders to weigh in on the vote, which has been delayed to April 30 Jared GnamApril 16, 2021
Industry update Aphria blames slump on Covid despite steady market growth CEO Simon says he expects to capture 30% of a $6B Canadian market following the Tilray merger and pandemic lifting Nick LabaApril 12, 2021
Canada How Aphria is fighting for more market share: marketing VP Q&A Although the Canadian company leads across several categories and jurisdictions, it's battling against price compression and packaging costs to win Nick LabaApril 9, 2021
Industry update Can you buy brand loyalty? Canopy thinks so While Canopy says its building authentic brands, weed industry insiders criticize the pot giant for attempting to buy brand loyalty instead of earning it Jared GnamApril 1, 2021
Industry update Hexo touts Q2 earnings, eyes M&A Once its deal to buy Zenabis closes, Hexo says it will be close to top-2 in Canadian recreational weed sales Jared GnamMarch 18, 2021
Analysis Is Hexo blowing smoke on Euro entry via Zenabis deal? While Hexo says a recent acquisition deal gives it 'immediate access' to Europe, records show Zenabis has yet to sell a gram in the... Jared GnamFebruary 24, 2021
Industry update Tilray’s pot sales pop ahead of Aphria merger Tilray stock rose 10% in after-hours trading Wednesday after the firm posted a better-than-expected Q4 loss of US$3M Jared GnamFebruary 17, 2021
Industry update Hexo to enter Europe with $265M Zenabis acquisition Hexo says the all-stock deal will gives it a top-3 spot in the Canadian cannabis market and a key foothold in Europe Jared GnamFebruary 16, 2021